Real-world Comparative Effectiveness of Rivaroxaban Versus VKA "RIVA-F"


Phase N/A Results N/A

Summary of Purpose

To obtain a better understanding on the comparative effectiveness of rivaroxaban versus VKA(Vitamin K antagonist) for stroke prevention in patients with NVAF(non-valvular atrial fibrillation) in a real-life setting

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 April 2017.

12 Feb 2016 19 Feb 2016 1 Mar 2016 1 Mar 2016 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample


Not available